A clinical trial to study the effects of two different dosages of Vitamin D in preterm neonates
Phase 4
Completed
- Registration Number
- CTRI/2020/08/027251
- Lead Sponsor
- niversity Research Grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 127
Inclusion Criteria
All preterm infants (28-34 weeks) born at or brought to NICU, KMC Manipal within 24 hours of life.
Exclusion Criteria
- Unable to tolerate 120 ml/kg enteral feeds by Day 14 of life
- Requiring surgical intervention
- Necrotizing enterocolitis
- Discharged against medical advice
- Expired
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 200 IU of supplementation to the current regimen of preterm feeding is necessary and sufficient to decrease morbidity in terms of decreasing the need for invasive/ non-invasive ventilation, the rate of culture proven or clinically suspected sepsis, and the duration and intensity of hyperbilirubinemia to clinically significant levels.Timepoint: 28 days
- Secondary Outcome Measures
Name Time Method Vit D supplementation aids in maintaining calcium homeostasisTimepoint: 28 days